Sung-soo S. Park

Seoul St. Mary's Hematology Hospital
Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 211 publications

Healthcare Jurisdiction as a Determinant of Real-World Survival in Transplant-Ineligible Multiple Myeloma: Lessons From a Three-Country East Asian Comparison.

Healthcare Jurisdiction as a Determinant of Real-World Survival in Transplant-Ineligible Multiple Myeloma: Lessons From a Three-Country East Asian Comparison.

Journal: European journal of haematology

Published: May 17, 2026

Nuanced treatment decision in newly diagnosed multiple myeloma patients aged 65-75 years: a real-world study.

Nuanced treatment decision in newly diagnosed multiple myeloma patients aged 65-75 years: a real-world study.

Journal: Blood research

Published: April 27, 2026

Population Pharmacokinetics and Model-Informed Precision Dosing of Lenalidomide Incorporating Total and Unbound Plasma Concentrations in Renally Impaired Patients with Multiple Myeloma.

Population Pharmacokinetics and Model-Informed Precision Dosing of Lenalidomide Incorporating Total and Unbound Plasma Concentrations in Renally Impaired Patients with Multiple Myeloma.

Journal: Drug design, development and therapy

Published: February 27, 2026

The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 study.

The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 study.

Journal: Haematologica

Published: February 25, 2026

A Simulation-Based Assessment of Dosage Regimen Appropriateness for Multiple Myeloma Medicines Reflecting Demographic and Ethnic Differences.

A Simulation-Based Assessment of Dosage Regimen Appropriateness for Multiple Myeloma Medicines Reflecting Demographic and Ethnic Differences.

Journal: Clinical and translational science

Published: January 23, 2026

Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study.

Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study.

Journal: Annals of hematology

Published: January 02, 2026

Long-term efficacy and safety of romiplostim plus immunosuppressive therapy as first-line treatment in patients with aplastic anaemia: 2-year interim analysis of observational study of two clinical trials.

Long-term efficacy and safety of romiplostim plus immunosuppressive therapy as first-line treatment in patients with aplastic anaemia: 2-year interim analysis of observational study of two clinical trials.

Journal: British journal of haematology

Published: December 05, 2025

Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65-69 Years (CAREMM-2110 study).

Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65-69 Years (CAREMM-2110 study).

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: November 19, 2025

Cell-derived vesicles extruded from adipose mesenchymal stem cells attenuate intestinal inflammation and augment epithelial regeneration in a colitis model.

Cell-derived vesicles extruded from adipose mesenchymal stem cells attenuate intestinal inflammation and augment epithelial regeneration in a colitis model.

Journal: Nanoscale

Published: November 13, 2025

Frontline ponatinib plus hyper-CVAD over imatinib in adults with Ph-positive acute lymphoblastic leukemia: realworld efficacy and risks of early ponatinib dose reduction.

Frontline ponatinib plus hyper-CVAD over imatinib in adults with Ph-positive acute lymphoblastic leukemia: realworld efficacy and risks of early ponatinib dose reduction.

Journal: Haematologica

Published: October 24, 2025

Real-world outcomes of SLiM-only multiple myeloma: Korean Multicenter Retrospective analysis (KMM2401 study).

Real-world outcomes of SLiM-only multiple myeloma: Korean Multicenter Retrospective analysis (KMM2401 study).

Journal: Annals of hematology

Published: October 21, 2025

Understanding the Unmet Needs in Diagnostics and Therapeutics of Chronic Lymphocytic Leukemia in Korea.

Understanding the Unmet Needs in Diagnostics and Therapeutics of Chronic Lymphocytic Leukemia in Korea.

Journal: Cancer research and treatment

Published: September 15, 2025

Showing 1-12 of 211

Last Updated: 09/26/2026